Sanofi
SNY
$48.32
Share price
0.04%
Change (1 day)
-3.82%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
EPS for Sanofi (SNY)
EPS in 2025 (TTM): $2.85
According to Sanofi's latest financial reports the company's current EPS (TTM) is $2.85. In 2023 the company made an earnings per share (EPS) of $2.32 a decrease over its 2022 EPS that were of $2.82.
EPS history for Sanofi from 2012 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | $2.85 | |
| 2023 | $2.32 | -17.77% |
| 2022 | $2.82 | |
| 2017 | $3.68 | 81.02% |
| 2016 | $2.03 | 11.92% |
| 2015 | $1.82 | -16.07% |
| 2014 | $2.16 | 15.33% |
| 2013 | $1.88 | -22.64% |
| 2012 | $2.43 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Merck MRK | $6.90 | 142.26% | 🇺🇸 USA |
 Pfizer PFE | $1.39 | -51.18% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $2.68 | -5.87% | 🇺🇸 USA |
 Novartis NVS | $6.43 | 125.84% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | $1.56 | -45.22% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$1.14 | -140.04% | 🇮🇱 Israel |
 Johnson & Johnson JNJ | $9.07 | 218.48% | 🇺🇸 USA |
 Eli Lilly LLY | $12.36 | 333.98% | 🇺🇸 USA |
 Novo Nordisk NVO | $3.34 | 17.20% | 🇩🇰 Denmark |
 Abbott Laboratories ABT | $7.79 | 173.49% | 🇺🇸 USA |